If symptoms of interstitial cystitis or bladder pain – like urinary problems or discomfort – impact everyday activities, you may qualify for a study.
The OAG1050 study is testing an investigational medication that is designed to help alleviate the symptoms of IC/BPS. The investigational medication is a tablet taken once daily before bed.
You may be able to join this study if you:
- Are a female between 18 and 70 years of age
- Have been diagnosed with interstitial cystitis or bladder pain syndrome or have been experiencing bladder pain, pressure or discomfort accompanied by a frequent need for urination that is not due to other causes (e.g. infection) and has persisted for at least six months.
- Are willing to travel to the clinic up to 9 times during an 8-week study treatment period.
- Are willing to use a computer or cell phone (can be your personal device) to monitor and record information daily about your pattern of pain and urination for the duration of the study.
There are other requirements for taking part in the OAG1050 study. If you are eligible and choose to participate, the study team will discuss additional study requirements, procedures and your rights and responsibilities with you.
Participation in the OAG1050 study lasts approximately 3.5 months and requires up to 9 visits to the study site.
If you qualify, you will receive – at no cost- access to the investigational medication, careful evaluation and frequent monitoring of your condition, and the opportunity to help advance the treatment of interstitial cystitis and bladder pain syndrome.
